|
Other Neuroleptics
Citations 131-140 of 280 total displayed.
|
Past content
(since Jan 1996):
|
- Letters to the Editor
Optimal Risperidone Dose in Drug-Naive, First-Episode Schizophrenia
- VASSILIS P. KONTAXAKIS, BEATA J. HAVAKI-KONTAXAKI, SOPHIA S. STAMOULI, and GEORGE N. CHRISTODOULOU
Am J Psychiatry 2000; 157: 1178-a-1179-a.
[Full text]
[PDF]
- Reviews and Overviews
Obesity: What Mental Health Professionals Need to Know
- Michael J. Devlin, Susan Z. Yanovski, and G. Terence Wilson
Am J Psychiatry 2000; 157: 854-866.
[Abstract]
[Full text]
[PDF]
- Articles
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
- David C. Henderson, Enrico Cagliero, Colin Gray, Rima A. Nasrallah, Doug L. Hayden, David A. Schoenfeld, and Donald C. Goff
Am J Psychiatry 2000; 157: 975-981.
[Abstract]
[Full text]
[PDF]
- Articles
Clozapine in the Treatment of Refractory Psychotic Mania
- Alan I. Green, Maricio Tohen, Jayendra K. Patel, Michael Banov, Curtiss DuRand, Ileana Berman, Howard Chang, Carlos Zarate, Jr., Joel Posener, Hang Lee, Ree Dawson, Carol Richards, Jonathan O. Cole, and Alan F. Schatzberg
Am J Psychiatry 2000; 157: 982-986.
[Abstract]
[Full text]
[PDF]
- Articles
Differential Efficacy of Olanzapine for Deficit and Nondeficit Negative Symptoms in Schizophrenia
- Alex Kopelowicz, Roberto Zarate, Konstantinos Tripodis, Veronica Gonzalez, and Jim Mintz
Am J Psychiatry 2000; 157: 987-993.
[Abstract]
[Full text]
[PDF]
- Articles
Relation of Familial Schizophrenia to Negative Symptoms But Not to the Deficit Syndrome
- Dolores Malaspina, Raymond R. Goetz, Scott Yale, Ariela Berman, Jill Harkavy Friedman, Fabien Tremeau, David Printz, Xavier Amador, Janet Johnson, Alan Brown, and Jack M. Gorman
Am J Psychiatry 2000; 157: 994-1003.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Retreatment With Clozapine After Erythromycin-Induced Neutropenia
- SASHA I. USISKIN, ROB NICOLSON, MARGE LENANE, and JUDITH L. RAPOPORT
Am J Psychiatry 2000; 157: 1021.
[Full text]
[PDF]
- ARTICLES
Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications
- Gregory A. Light, Mark A. Geyer, Brett A. Clementz, Kristin S. Cadenhead, and David L. Braff
Am J Psychiatry 2000; 157: 767-771.
[Abstract]
[Full text]
[PDF]
- BRIEF REPORTS
Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia
- A. Eden Evins, Sandra M. Fitzgerald, Lara Wine, Roseanne Rosselli, and Donald C. Goff
Am J Psychiatry 2000; 157: 826-828.
[Abstract]
[Full text]
[PDF]
- LETTERS TO THE EDITOR
Amphetamine Misuse and Social Phobia
- KELWYN WILLIAMS, SPILIOS ARGYROPOULOS, and DAVID J. NUTT
Am J Psychiatry 2000; 157: 834-a-835-a.
[Full text]
[PDF]
|
|
